This vacci e targets the origi al SARS-CoV-2 virus from 2019 a d the Omicro (BA.1) varia t OTTAWA, ON, Sept. 1, 2022 – Today, Health Ca ada authorized a adapted versio of the Moder a Spikevax COVID-19 vacci e. This vacci e (k ow as a “bivale t” vacci e) targets the origi al SARS-CoV-2 virus from 2019 a [...]